Value Based Healthcare requires a new way of thinking. It requires fluently navigating clinical outcomes and economic costing. This presentation will cover WHY VBHC is necessary, HOW Value based procurement enables VBHC, WHO needs to be involved in the collaborative dialogue, and WHAT the role of VBAPs are in overcoming clinical and economic uncertainty to drive medtech adoption.
Ernesto M. Nogueira
CEO and Founder
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.